AVA-TRAP

Pharmaceutical preparations and components thereof for treatment of infectious disease, namely, QTY-code designed cytokine and chemokine receptor protein variants with antibody-like properties used to trap cytokines, chemokines and inflammatory mediators released by immune effector cells during pathophysiological conditions, including but not limited to cytokine release syndrome associated with CAR-T therapy, Coronavirus-induced lung damage, and other such similar pathophysiological conditions